Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Income Retained in Business
QFRNIRB385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
11,567.00
Year-over-Year Change
-11.92%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks the net income retained by pharmaceutical and medicine corporations in the United States each quarter. It provides critical insight into the financial health and reinvestment strategies of a key sector in the U.S. economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the portion of corporate earnings that companies choose to keep and reinvest rather than distribute as dividends or use for other purposes. Economists analyze this trend to understand corporate financial strategies, investment potential, and sector-specific economic performance.
Methodology
Data is collected through comprehensive quarterly financial reports submitted by pharmaceutical and medicine corporations to regulatory agencies.
Historical Context
This indicator is used by policymakers, investors, and economic analysts to assess the financial resilience and growth potential of the pharmaceutical industry.
Key Facts
- Reflects corporate financial strategy in the pharmaceutical sector
- Indicates potential for future research and development investments
- Provides insight into sector-specific economic performance
FAQs
Q: What does net income retained in business mean?
A: Net income retained represents the portion of corporate earnings that a company keeps to reinvest in its operations, rather than distributing to shareholders as dividends.
Q: Why is this metric important for the pharmaceutical industry?
A: It shows how much capital pharmaceutical companies are preserving for future research, development, and strategic investments in new medical technologies.
Q: How frequently is this data updated?
A: The data is typically updated quarterly, providing a current snapshot of the pharmaceutical sector's financial performance.
Q: How do investors use this information?
A: Investors analyze this metric to assess a company's financial health, growth potential, and strategic reinvestment capabilities.
Q: What are the limitations of this indicator?
A: While informative, this metric should be considered alongside other financial indicators for a comprehensive understanding of corporate performance.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Food and Beverage Stores: Inventories
QFR214445USNO
Quarterly Financial Report: U.S. Corporations: All Mining: Retained Earnings
QFR322MINUSNO
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Income (Loss) Before Income Taxes
QFR111385USNO
Quarterly Financial Report: U.S. Corporations: Basic Chemicals, Resins, and Synthetics: Retained Earnings at Beginning of Quarter
QFRD119375USNO
Quarterly Financial Report: U.S. Corporations: All Other Electronic Products: Other Short-Term Financial Investments
QFRD210334USNO
Quarterly Financial Report: U.S. Corporations: All Professional and Technical Services, Except Legal Services: Total Current Assets
QFRTCAPTSUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Income Retained in Business [QFRNIRB385USNO], retrieved from FRED.
Last Checked: 8/1/2025